deferiprone and natriuretic peptide, brain

deferiprone has been researched along with natriuretic peptide, brain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agus, A; Dessi, C; Galanello, R; Nair, SV; Pennell, DJ; Pibiri, M; Smith, GC; Tanner, MA; Walker, JM; Westwood, MA	1

Trials

1 trial(s) available for deferiprone and natriuretic peptide, brain

Article	Year
Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2008, Feb-25, Volume: 10 Topics: Administration, Oral; Adult; beta-Thalassemia; Cardiomyopathies; Deferiprone; Deferoxamine; Drug Therapy, Combination; Female; Ferritins; Humans; Injections, Subcutaneous; Iron; Iron Chelating Agents; Italy; Liver; Magnetic Resonance Imaging; Male; Myocardium; Natriuretic Peptide, Brain; Prospective Studies; Pyridones; Severity of Illness Index; Siderosis; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left	2008

Article

Year

Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2008, Feb-25, Volume: 10

Topics: Administration, Oral; Adult; beta-Thalassemia; Cardiomyopathies; Deferiprone; Deferoxamine; Drug Therapy, Combination; Female; Ferritins; Humans; Injections, Subcutaneous; Iron; Iron Chelating Agents; Italy; Liver; Magnetic Resonance Imaging; Male; Myocardium; Natriuretic Peptide, Brain; Prospective Studies; Pyridones; Severity of Illness Index; Siderosis; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left

2008